Negative regulation of leukocyte mediated immunity

pathway activity — cross-omics
GO:0002704Cross-omicsPROTEIN-MS → PROTEIN-MSCellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of leukocyte mediated immunity pathway is significantly associated with the protein abundance of multiple proteins, with the BLOOD_Lymphoma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are HLA-G, ZYX, and HLA-B, each associated with the pathway in up to 14 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of leukocyte mediated immunity activity versus HLA-G in BLOOD_Lymphoma (Pearson r = 0.52).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LymphomaHLA-G →+2.507+0.243<.001<.001314
LUNG_NSCLC_LUSCZYX →+2.115+0.379.004.002311
BREASTHLA-B →+2.588+0.305.001.004212
BLOOD_LeukemiaHLA-A →+2.510+0.480<.001<.001310
STOMACHB2M →+2.217+0.304.003.008210
SKINNECTIN2 →+1.188+0.222<.001<.00137
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002704 vs HLA-G — BLOOD_Lymphoma

Per-sample scatter of Negative regulation of leukocyte mediated immunity activity vs HLA-G in BLOOD_Lymphoma.

Explore this scatter interactively →

Exploration